Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma

American Journal of Clinical Pathology

Volumn 130, Issue 5, 2008, Pages 736-744

  Elsheikh, Tarik M ^a   Asa, Sylvia L ^b   Chan, John K C ^c   DeLellis, Ronald A ^d   Heffess, Clara S ^e   LiVolsi, Virginia A ^f   Wenig, Bruce M ^g  

^a BALL MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^d RHODE ISLAND HOSPITAL   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Adenoma; Follicular; Observer variation; Papillary carcinoma; Thyroid

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL NUCLEUS MEMBRANE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; ADENOCARCINOMA; ADENOMA; CELL NUCLEUS; DIAGNOSTIC ERROR; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; STANDARD; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADULT; CARCINOMA, PAPILLARY, FOLLICULAR; CELL NUCLEUS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY, SURGICAL; THYROID NEOPLASMS;

EID: 55249098863     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPKP2QUVN4RCCP     Document Type: Article

References (49)

1. Renshaw AA, Gould EW. Why there is the tendency to " overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002;117:19-21.
2. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000;13:861-865.
3. Albores-Saavedra J, Gould E, Vardaman C, et al. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol. 1991;22:1195-1205.
4. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117:143-150.
5. Baloch ZW, Gupta PK, Yu GH, et al. Follicular variant of papillary carcinoma: cytologic and histologic correlation. Am J Clin Pathol. 1999;111:216-222.
6. Rosai J. Thyroid gland. In: Rosai and Ackerman's Surgical Pathology. Philadelphia, PA: Elsevier; 2004:515-594.
7. Baloch ZW, LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol. 2007;60:244-250.
8. Fusco A, Chiappetta G, Hui P, et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol. 2002;160:2157-2167.
9. Williams ED. Two proposals regarding the terminology of thyroid tumors [editorial]. Int J Surg Pathol. 2000;8:181-183.
10. Vickery AL Jr. Thyroid papillary carcinoma: pathological and philosophical controversies. Am J Surg Pathol. 1983;7:797-807.
11. Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002;117:16-18.
12. Ivanova R, Soares P, Castro P, et al. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch. 2002;440:418-424.
13. Tischler AS, DeLellis RA. Tumors of thyroid follicular epithelium: where have we been and where are we going? Endocr Pathol. 2002;13:267-269.
14. Rosai J, Zampi G, Carcangiu ML. Papillary carcinoma of the thyroid: a discussion of its several morphologic expressions, with particular emphasis on the follicular variant. Am J Surg Pathol. 1983;7:809-817.
15. Baloch ZW, LiVolsi VA. Etiology and significance of the optically clear nucleus. Endocr Pathol. 2002;13:289-299.
16. LiVolsi VA. Papillary neoplasms of the thyroid: pathologic and prognostic features. Am J Clin Pathol. 1992;97:426-434.
17. Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. Hum Pathol. 2001;32:24-30.
18. Emmrich P, Gauer G, Gauer J, et al. A comparative study of cytological and histological studies of the thyroid gland [in German]. Zentralbl Chir. 2001;126:267-272.
19. Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336-1340.
20. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26:1508-1514.
21. Franssila KO, Ackerman LV, Brown CL, et al. Follicular carcinoma. Semin Diagn Pathol. 1985;2:101-122.
22. Schroder S, Pfannschmidt N, Dralle H, et al. The encapsulated follicular carcinoma of the thyroid: a clinicopathologic study of 35 cases. Virchows Arch A Pathol Anat Histopathol. 1984;402:259-273.
23. Ron E, Griffel B, Liban E, et al. Histopathologic reproducibility of thyroid disease in an epidemiologic study. Cancer. 1986;57:1056-1059.
24. Saxen EA, Fransilla K, Hakama M. Effect of histological typing of registry material on the results of epidemiological comparisons in thyroid cancer. In: Hedinger C, ed. Thyroid Cancer. New York, NY: Springer-Verlag; 1969:98-103. IUCC Monograph Series; Vol 12.
25. Holm LE, Löwhagen T, Silfverswärd C. The reliability of malignant thyroid tumor diagnosis in the Swedish Cancer Registry: review of 200 cases. Acta Pathol Microbiol Scand [A]. 1980;88:251-254.
26. Franc B, de la Salmoniere P, Lange F, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol. 2003;34:1092-1100.
27. Fassina AS, Montesco MC, Ninfo V, et al. Histological evaluation of thyroid carcinomas: reproducibility of the "WHO" classification. Tumori. 1993;79:314-320.
28. Al-Brahim NYY, Asa SL. Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med. 2006;130:1057-1062.
29. Chan JKC. Tumors of the thyroid and parathyroid glands. In: Fletcher DM, ed. Diagnostic Histopathology of Tumors. 3rd ed. New York, NY: Churchill Livingstone; 2007:chap 18.
30. Baloch ZW, LiVolsi VA. Diagnostic dilemmas in thyroid pathology: follicular variant of papillary thyroid carcinoma and classic papillary thyroid carcinoma arising in lymphocytic thyroiditis. Pathol Case Rev. 2003;8:47-56.
31. Kawachi K, Matsushita Y, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol. 2000;31:428-433.
32. Cheung CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14:338-342.
33. Baloch ZW, LiVolsi VA. The quest for a magic tumor marker: continuing saga in the diagnosis of the follicular lesions of thyroid [editorial]. Am J Clin Pathol. 2002;118:165-166.
34. Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations. Am J Clin Pathol. 2003;120:71-77.
35. Asa S. The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid. Endocr Pathol. 2005;16:295-310.
36. Barden CB, Shister KW, Zhu B, et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res. 2003;9:1792-1800.
37. Carta C, Moretti S, Passeri L, et al. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf). 2006;64:105-109.
38. Fukushima T, Suzuki S, Mashiko M, et al. BRAF mutations in papillary carcinomas of the thyroid. Oncogene. 2003;22:6455-6457.
39. Giordano TJ, Kuick R, Thomas DG, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/ PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646-6656.
40. Kroll TG. Molecular events in follicular thyroid tumors. Cancer Treat Res. 2004;122:85-105.
41. Quiros RM, Ding HG, Gattuso P, et al. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103:2261-2268.
42. Inaba M, Umemura S, Satoh H, et al. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathol Int. 2003;53:146-153.
43. Adeniran AJ, Zhu Z, Gandhi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 2006;30:216-222.
44. Wreesmann VB, Ghossein RA, Hezel M, et al. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004;40:355-364.
45. DeLellis RA, Lloyd RV, Heitz PU, et al, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
46. Franc B. Observer variation of lesions of the thyroid. Am J Surg Pathol. 2003;27:1177-1179.
47. Kakudo K, Katoh R, Sakamoto A, et al. Thyroid gland: international case conference. Endocr Pathol. 2002;13:131-134.
48. Hirokawa M, DeLellis RA, Kakudo K. Observer variation of lesions of the thyroid [letter]. Am J Surg Pathol. 2003;27:1178-1179.
49. LiVolsi VA. Can we agree to disagree [editorial]? Hum Pathol. 2003;34:1081-1082.